TQB-2805

N/A

Report date: 2025/01/26 15:44:20

Base Information

Drug NameTQB-2805
Drug Alias NameTQB-2805
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A